Ultra-High Prostate-Specific Antigen Level: A Potential Very-High-Risk Factor for Localized High-Risk Prostate Cancer

Ultra-High Prostate-Specific Antigen Level: A Potential Very-High-Risk Factor for Localized High-Risk Prostate Cancer

To examine the impact of ultra-high iPSA levels of >50 ng/mL (uhPSA) after modern radiotherapy, we compared outcomes of 214 patients with uhPSA levels to 1161 other high-risk patients. Radiotherapy included brachytherapy ± external beam radiotherapy (EBRT) and EBRT alone (intensity-modulated radi...

Full description

Bibliographic Details
Main Authors: Hideya Yamazaki, Gen Suzuki, Koji Masui, Kei Yamada, Takashi Ueda, Takumi Shiraishi, Atsuko Fujihara, Takashi Kato, Yasutoshi Hashimoto, Haruumi Okabe
Format: Article
Language:English
Published: MDPI AG 2023-11-01
Series:Cancers
Subjects:
prostate cancer
brachytherapy
intensity modulated radiotherapy
stereotactic body radiotherapy
prostate-specific antigen (PSA)
Online Access:https://www.mdpi.com/2072-6694/15/23/5644

Internet

https://www.mdpi.com/2072-6694/15/23/5644

Similar Items